<DOC>
	<DOCNO>NCT01885572</DOCNO>
	<brief_summary>This multicentre , non-randomised , observational clinical device investigation perform obtain postmarketing information TiLOOP® Bra particular improvement patient ' quality life well rate complication device investigation . The objective clinical investigation establish feasibility , efficacy safety TiLOOP® Bra .</brief_summary>
	<brief_title>National , Multicenter PMS Study `` Patient Reported Outcome '' Breast Reconstruction Following Mastectomy With TiLOOP Bra</brief_title>
	<detailed_description />
	<criteria>The TiLOOP®Bra design assist oncologically indexed skin spar mastectomy subcutaneous mastectomy preservation nippleareolacomplex primary breast reconstruction , secondary breast reconstruction corrective breast surgery . Patients shall include meet follow criterion : Clinical Criteria ( reason ) : woman indication prophylactic operation oncoplastic operation support mesh implant woman histologically confirm breast cancer precancerosis genetic preexisting condition increase risk breast cancer family history health woman must comply ECOG ( Eastern Cooperative Oncology Group ) performance status 02 Studyrelated inclusion criterion Legal reason : Patient mentally able understand nature , aim , possible consequence clinical investigation Patient information hand write consent hand . Patient 18 75 year old . Patients must exclude follow condition exist exclude : Devicerelated exclusion criterion ( contraindication ) : Pathological physical condition precluding : Pregnancy breastfeed patient Known intolerance meshimplants investigation . Studyrelated exclusion criterion Medical reason : metastatic breast cancer medicamentous regulate diabetes blood sugar level &gt; 250 inadequate bone marrow function neutrophil granulocytes &lt; 1500 blood plate &lt; 10000/µl patient know contraindication meshimplants plasticreconstructive breast operation Studyrelated exclusion criterion Legal reason : Lack write patient informed consent . Lack patient compliance regard data collection , treatment followup investigation scope protocol . Patient institutionalized court official order ( MPG§20.3 ) . Participation another operative clinical investigation . It think studyrelated exclusion criterion significantly influence sample population investigation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>breast reconstruction</keyword>
	<keyword>mastectomy</keyword>
	<keyword>mesh</keyword>
	<keyword>breast cancer</keyword>
</DOC>